
PENSIA 2.5 gm
December 24, 2024
PROXICARE-P
February 12, 2025ENROSIA-F 30ML
flunixin 50mg
ENROSIA-F 30ML Injection is a powerful dual-action veterinary injectable, combining Enrofloxacin, a broad-spectrum fluoroquinolone antibiotic, with Flunixin Meglumine, a potent non-steroidal anti-inflammatory drug (NSAID). Formulated by Avosia Pharma, this injection is designed for effective management of bacterial infections accompanied by pain, inflammation, and fever in cattle, buffaloes, goats, sheep, and other livestock.
Indications
ENROSIA-F is indicated for the treatment of:
Respiratory tract infections
Mastitis-Metritis-Agalactia (MMA) syndrome
Septicaemia
Enteritis and colibacillosis
Musculoskeletal inflammation
Post-surgical inflammation and fever
Mixed bacterial infections with associated inflammation and pain
Key Benefits
✅ Broad-spectrum antibacterial action from Enrofloxacin
✅ Rapid anti-inflammatory and antipyretic effects from Flunixin
✅ Dual therapy for better recovery in systemic infections
✅ Reduces stress, pain, and inflammation in infected animals
✅ Promotes faster return to normal appetite and activity
Composition | Enrofloxacin I.P. 150mg + flunixin meglumine I.P. 83mg |
---|